Stifel Nicolaus restated their buy rating on shares of Cempra (NASDAQ:CEMP) in a report released on Thursday. Stifel Nicolaus currently has a $22.00 price objective on the stock, up from their previous price objective of $19.00. Cempra, Inc. (NASDAQ:CEMP) belongs to Healthcare sector. Its weekly performance is 1.14%. On last trading day company shares ended up $14.16. Cempra, Inc. (NASDAQ:CEMP) distance from 50-day simple moving average (SMA50) is 20.58%. Healthcare products maker Kimberly-Clark Corporation (NYSE:KMB) said Thursday its board authorized a new share repurchase program for up to 40 million shares of common stock or $5 billion. The authorization augments the current 50 million share authorization from January 2011 that is expected to be completed in the first quarter of 2015. Kimberly-Clark Corporation (NYSE:KMB) belongs to Consumer Goods sector. Its net profit margin is 10.10% and weekly performance is 0.90%. On last trading day company shares ended up $114.07. Kimberly-Clark Corporation (NYSE:KMB) distance from 50-day simple moving average (SMA50) is 8.26%.Orient Paper, Inc. (NYSEMKT:ONP) announced unaudited financial results for the third quarter ended September 30, 2014. Total Revenue in the third quarter of 2014 was $40.8 million, representing an increase of 8.1% from $37.7 million in the prior year period. On 13 November, Orient Paper, Inc. (NYSEMKT:ONP) shares increased 1.65% and was closed at $1.23. ONP EPS growth in last 5 year was -1.60%. Orient Paper, Inc. (NYSEMKT:ONP) year to date (YTD) performance is -53.76%. Pursuant to the terms of the relevant product prospectuses, each dated as of March 20, 2014, Barclays PLC (ADR) (NYSE:BCS) announced the upcoming maturity of the following two exchange traded notes (“ETNs”): Barclays ETN+ Long B Leveraged Exchange Traded Notes Linked to the S&P 500® Total Return Index (ticker “BXUB”) ; Barclays ETN+ Long C Leveraged Exchange Traded Notes Linked to the S&P 500® Total Return Index (ticker “BXUC”). Barclays PLC (ADR) (NYSE:BCS) ended the last trading day at $14.43. Company weekly volatility is calculated as 0.90%. Barclays PLC (ADR) (NYSE:BCS) showed a weekly performance of -3.86%. Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) announced that Todd C. Brady, M.D., Ph.D., President and CEO of Aldeyra, will present a general corporate overview at the Therapeutic Area Partnerships (TAP) meeting scheduled to take place November 19-21, 2014 in Boston, MA. Dr. Brady will present at 10:50AM ET as part of the "Top Projects to Watch" within the anti-inflammatory/autoimmune industry. Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) shares increased 5.18% in last trading session and ended the day at $7.91. ALDX return on assets is -73.60%. Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) quarterly performance is 96.76%.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
